Stage IIIB/IV
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations. (NCT01525199) | AstraZeneca | 2012-05-01 |
Track Stage IIIB/IV automatically
Every clearance here is in the API, with alerts when new ones post.